skip to Main Content

Spinraza EAP opens in Russia

  • 23 April 2019

Today marks another development in global availability of Spinraza, the first and only approved treatment for spinal muscular atrophy. As announced by SMA Family Russia and Biogen, an Expanded Access Programme is due to start in Russia today. 

Read More
Back To Top